title: Coated stents for the prevention of restenosis: Part II.
authors.affiliation: Division of Cardiology, Montreal General Hospital/McGill University, Montreal, Quebec, Canada.
authors.forename: Mohan N
authors.initials: MN
authors.lastname: Babapulle
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Eisenberg
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D020099:Coated Materials, Biocompatible / Q000008:administration & dosage* / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000601:surgery; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control*; D003331:Coronary Vessels / Q000187:drug effects / Q000601:surgery; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000009:adverse effects; D004343:Drug Implants / Q000008:administration & dosage / Q000009:adverse effects; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006046:Gold / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D010767:Phosphorylcholine / Q000008:administration & dosage; D055502:Secondary Prevention; D015607:Stents / Q000009:adverse effects / Q000592:standards / Q000639:trends; D013256:Steroids / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D000970:Antineoplastic Agents; D020099:Coated Materials, Biocompatible; D003692:Delayed-Action Preparations; D004343:Drug Implants; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D013256:Steroids; D010767:Phosphorylcholine; D006046:Gold